A novel enhancer-AAV approach selectively targeting dentate granule cells

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The mammalian brain exhibits remarkable cellular diversity, with specialized neuronal subtypes crucial for complex circuit operations and behavior.
• Cre-lox systems have enabled targeted genetic manipulation of specific neuron types, but their development is costly and limits clinical translatability.
• Adeno-Associated Virus (AAV) vectors with neuron-type-specific regulatory elements offer a promising alternative for precise cell targeting.

Approach:

• Evaluated publicly available RNA sequencing data to identify candidate enhancers for neuron-type-specific targeting.
• Developed and tested Adeno-Associated Virus (AAV) vectors engineered with neuron-type-specific regulatory transcriptional sequences (enhancer-AAVs).
• Validated the selectivity of a promising enhancer-AAV for targeting dentate granule cells in the hippocampus of wild-type adult mice.

Key Points:

• Identified a novel enhancer-AAV with high selectivity for dentate granule cells.
• Demonstrated the potential of enhancer-AAVs as a more accessible and efficient alternative to traditional Cre-lox systems.
• Validated the in vivo targeting capability in a relevant biological model.

Conclusions:

• The developed enhancer-AAV provides a powerful and efficient tool for targeting dentate granule cells.
• This approach enhances the potential for developing neuron-type-specific genetic tools and cell-based therapeutics.
• This method offers improved clinical translatability compared to traditional Cre-lox strategies.